The value of different 18F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients
- PMID: 30219989
- DOI: 10.1007/s12149-018-1301-9
The value of different 18F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients
Abstract
Objective: Administration of postoperative chemotherapy to patients with completely resected stage I NSCLC is still a matter of debate. The aim of the present study was to evaluate the value of different baseline 18F-FDG PET parameters in identifying surgical stage I NSCLC patients who are at high risk of recurrence, and thus are indicated for further postoperative treatment.
Methods: This is a retrospective study, which included 49 patients (28 males, 21 females) with the median age of 69 years (range 28-84), who had pathologically proven stage I NSCLC. All patients underwent 18F-FDG PET/CT at baseline followed by complete surgical resection of the tumor (R0). Baseline SUVmax, MTV and TLG were measured. Patients' follow-up records were retrospectively reviewed, and DFS (disease-free survival) was assessed. For each parameter, the most accurate cut-off value for the prediction of recurrence was calculated using the ROC curve analysis and the Youden index. DFS was evaluated for patients above and below the calculated cut-off value using the Kaplan-Meier method and the difference in survival between the two groups was estimated using the log-rank test.
Results: Median observation time of the patients after surgery was 28.7 months (range 3.5-58.8 months). 9 patients developed recurrence. The calculated cut-off values for SUVmax, MTV and TLG were 6, 6.6 and 33.6, respectively. Using these cut-offs, the observed sensitivity for SUVmax, MTV and TLG for prediction of recurrence was 100%, 89% and 89%, respectively, while the observed specificity was 43%, 73% and 65%, respectively. The difference in survival between patients below and above the cut-off value was statistically significant in all three studied parameters. The highest AUC was observed for MTV (AUC = 0.825, p = 0.003), followed by TLG (AUC = 0.789, p = 0.007), and lastly SUVmax (AUC = 0.719, p = 0.041). ROC curve analysis showed that volumetric parameters had better predictive performance than SUVmax as regards recurrence.
Conclusion: PET-derived parameters at baseline were predictive of recurrence in stage I surgical NSCLC patients. Moreover, the metabolic volume of the tumor was the most significant parameter for this purpose among the studied indices.
Keywords: 18F-FDG PET/CT; MTV; NSCLC; Recurrence; SUVmax; TLG.
Similar articles
-
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983. doi: 10.1007/s00259-017-3753-x. Epub 2017 Jul 8. Eur J Nucl Med Mol Imaging. 2017. PMID: 28689281 Free PMC article. Clinical Trial.
-
Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.Ann Surg. 2013 Feb;257(2):364-70. doi: 10.1097/SLA.0b013e318262a6ec. Ann Surg. 2013. PMID: 22968069
-
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19. Acad Radiol. 2013. PMID: 22999369
-
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.PLoS One. 2016 Jan 4;11(1):e0146195. doi: 10.1371/journal.pone.0146195. eCollection 2016. PLoS One. 2016. PMID: 26727114 Free PMC article. Review.
-
Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):241-51. doi: 10.1007/s00259-014-2903-7. Epub 2014 Sep 6. Eur J Nucl Med Mol Imaging. 2015. PMID: 25193652
Cited by
-
18F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.J Nucl Cardiol. 2023 Dec;30(6):2400-2414. doi: 10.1007/s12350-023-03285-5. Epub 2023 Jun 1. J Nucl Cardiol. 2023. PMID: 37264215 Free PMC article.
-
SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients.Eur Radiol. 2022 Jun;32(6):3889-3902. doi: 10.1007/s00330-021-08523-3. Epub 2022 Feb 8. Eur Radiol. 2022. PMID: 35133484
-
PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer.EJNMMI Res. 2020 May 19;10(1):51. doi: 10.1186/s13550-020-00639-9. EJNMMI Res. 2020. PMID: 32430866 Free PMC article.
-
Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?J Cancer Res Clin Oncol. 2019 Apr;145(4):1021-1026. doi: 10.1007/s00432-019-02858-7. Epub 2019 Feb 13. J Cancer Res Clin Oncol. 2019. PMID: 30756189 Free PMC article.
-
PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients.Diagnostics (Basel). 2021 Jan 30;11(2):210. doi: 10.3390/diagnostics11020210. Diagnostics (Basel). 2021. PMID: 33573333 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical